Pertussis in infants in Nordic countries

Amit Bhavsar1, Jussi Mertsola2, Anja Poulsen3

  • 1Epidemiology & Health Economics, GSK, Wavre, Belgium.

Insights

A life-course immunization strategy is crucial for pertussis control. Higher infant pertussis incidence in Denmark may stem from lacking adolescent booster vaccine recommendations, unlike other Nordic countries.

Area of Science:

  • Public Health
  • Epidemiology
  • Immunization Practices

Background:

  • Pertussis (whooping cough) remains a significant public health concern, particularly for infants.
  • Effective control requires a comprehensive life-course immunization approach.
  • Understanding pertussis incidence in relation to vaccination strategies is vital for Nordic countries.

Purpose of the Study:

  • To review pertussis incidence among infants in Denmark, Finland, Norway, and Sweden (2014-2018).
  • To analyze national surveillance systems and infant vaccination schedules.
  • To contextualize pertussis incidence within existing immunization policies.

Main Methods:

  • Collected data on pertussis incidence, vaccination schedules, and DTaP vaccine coverage (infancy).
  • Utilized publicly available data sources and expert opinions on national surveillance.
  • Compared vaccination schedules, including adolescent boosters and maternal immunization recommendations.

Main Results:

  • Infant vaccination schedules and DTaP vaccine coverage were similar across the four Nordic countries.
  • Denmark, Sweden, and Finland reported mean pertussis incidences of 168, 76, and 35 per 100,000 infant-years, respectively.
  • Adolescent booster recommendations were present in all countries except Denmark; maternal immunization was not recommended in any.

Conclusions:

  • The higher pertussis incidence in Denmark may be linked to the absence of adolescent booster vaccination recommendations.
  • National surveillance systems showed no systematic differences across the studied countries.
  • Further research is warranted to investigate the impact of adolescent boosters on pertussis control.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.0K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.5K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
502
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
323
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
583